Selvita S.A. (FRA:787)

Market Cap	73.40M -54.6%
Revenue (ttm)	81.19M -6.7%
Net Income	-484.33K
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	22.28
Dividend	n/a
Ex-Dividend Date	n/a

Volume	28
Open	3.900
Previous Close	4.125
Day's Range	3.900 - 3.900
52-Week Range	3.900 - 11.050
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 19, 2026

About Selvita

Selvita S.A. provides drug discovery, drug development, and contract testing services in Poland. The company offers computer-aided drug design and artificial intelligence solutions, including structure-based drug design, virtual screening, and bioinformatics; medicinal and synthetic, analytical, and solid state chemistry, as well as process chemistry and scale up, and compound management and libraries; structural biology, fragment-based drug discovery, protein production, modification, and characterization; vitro assays and model, mechanistic a...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2007
• Employees: 899
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 787

Financial Performance

Financial numbers in PLN

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error